Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Current targeted therapies designed to inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein have made a significant breakthrough in the treatment of CML patients. However, CML remains a chronic disease that a patient...
Saved in:
Main Authors: | Ahmad Hamad (Author), Zeyad Sahli (Author), Maya El Sabban (Author), Maha Mouteirik (Author), Rihab Nasr (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
by: Andrew Wu, et al.
Published: (2023) -
Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
by: Habsah Aziz, et al.
Published: (2017) -
Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024) -
Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia
by: Xing Bian, et al.
Published: (2024) -
Development and targeted use of nilotinib in chronic myeloid leukemia
by: Carmen Fava, et al.
Published: (2008)